1. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability;Anderson;J. Affect. Disord.,2000
2. Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression;Andreoli;J. Clin. Psychiatry,2002
3. Bupropion: a review of its mechanism of antidepressant activity;Ascher;J. Clin. Psychiatry,1995
4. Chronic α-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid receptor potentiator (LY451646) increases cell proliferation in adult rat hippocampus;Bai;Neuropharmacology,2003
5. EMD 68843, a serotonin reuptake inhibitor with presynaptic 5-HT1A receptor agonistic properties;Bartoszyk;Eur. J. Pharmacol.,1997